News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cyclacel Pharmaceuticals, Inc. (CYCC) to Present at Lazard Healthcare Conference



11/7/2012 9:19:23 AM

BERKELEY HEIGHTS, N.J., Nov. 7, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, announced today that Spiro Rombotis, President and Chief Executive Officer, will present at the Lazard Capital Markets 9th Annual Healthcare Conference at The Pierre Hotel in New York City. Cyclacel's presentation will take place on Tuesday, November 13th at 9:00 a.m. Eastern Time.

Read at GlobeNewswire

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES